These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 18813838

  • 1. The influence of 1,25-dihydroxyvitamin D3 and 1,24-dihydroxyvitamin D3 on alphavbeta3 integrin expression in cancer cell lines.
    Wietrzyk J, Filip B, Milczarek M, Klopotowska D, Maciejewska M, Dabrowska K, Kurzepa A, Dzimira S, Madej J, Kutner A.
    Oncol Rep; 2008 Oct; 20(4):941-52. PubMed ID: 18813838
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model.
    Wietrzyk J, Nevozhay D, Milczarek M, Filip B, Kutner A.
    Cancer Chemother Pharmacol; 2008 Oct; 62(5):787-97. PubMed ID: 18188568
    [Abstract] [Full Text] [Related]

  • 4. [Cell differentiation and down regulation of nm23 gene expression in HL-60 cells induced by 1,25 dihydroxyvitamin D3].
    Zhu N, Lu Q, Zhou Y.
    Zhonghua Xue Ye Xue Za Zhi; 2001 Dec; 22(12):639-41. PubMed ID: 16200712
    [Abstract] [Full Text] [Related]

  • 5. Correlation between VDR expression and antiproliferative activity of vitamin D3 compounds in combination with cytostatics.
    Pelczynska M, Wietrzyk J, Jaroszewicz I, Nevozhay D, Switalska M, Kutner A, Zabel M, Opolski A.
    Anticancer Res; 2005 Dec; 25(3B):2235-40. PubMed ID: 16158969
    [Abstract] [Full Text] [Related]

  • 6. Toxicity and antineoplastic effect of (24R)-1,24-dihydroxyvitamin D3 (PRI-2191).
    Wietrzyk J, Pełczyńska M, Madej J, Dzimira S, Kuśnierczyk H, Kutner A, Szelejewski W, Opolski A.
    Steroids; 2004 Sep; 69(10):629-35. PubMed ID: 15465107
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Tumor suppressor KAI1 affects integrin alphavbeta3-mediated ovarian cancer cell adhesion, motility, and proliferation.
    Ruseva Z, Geiger PX, Hutzler P, Kotzsch M, Luber B, Schmitt M, Gross E, Reuning U.
    Exp Cell Res; 2009 Jun 10; 315(10):1759-71. PubMed ID: 19371633
    [Abstract] [Full Text] [Related]

  • 9. The third multidisciplinary conference on drug research, Piła 2002. Effects of 1alpha,25-dihydroxyvitamin D3 and some putative steroid neuroprotective agents on the hydrogen peroxide-induced damage in neuroblastoma-glioma hybrid NG108-15 cells.
    Tetich M, Leśkiewicz M, Budziszewska B, Basta-Kaim A, Kutner A, Lasoń W.
    Acta Pol Pharm; 2003 Jun 10; 60(5):351-5. PubMed ID: 15005417
    [Abstract] [Full Text] [Related]

  • 10. Antitumor properties of diastereomeric and geometric analogs of vitamin D3.
    Wietrzyk J, Chodyński M, Fitak H, Wojdat E, Kutner A, Opolski A.
    Anticancer Drugs; 2007 Apr 10; 18(4):447-57. PubMed ID: 17351397
    [Abstract] [Full Text] [Related]

  • 11. The effect of combined treatment on head and neck human cancer cell lines with novel analogs of calcitriol and cytostatics.
    Wietrzyk J, Milczarek M, Kutner A.
    Oncol Res; 2007 Apr 10; 16(11):517-25. PubMed ID: 18306931
    [Abstract] [Full Text] [Related]

  • 12. Influence of vitamin D(3) analogues in combination with budesonid R on proliferation of nasal polyp fibroblasts.
    Rostkowska-Nadolska B, Fraczek M, Gawron W, Latocha M.
    Acta Biochim Pol; 2009 Apr 10; 56(2):235-42. PubMed ID: 19503845
    [Abstract] [Full Text] [Related]

  • 13. Expression of estrogen receptor beta increases integrin alpha1 and integrin beta1 levels and enhances adhesion of breast cancer cells.
    Lindberg K, Ström A, Lock JG, Gustafsson JA, Haldosén LA, Helguero LA.
    J Cell Physiol; 2010 Jan 10; 222(1):156-67. PubMed ID: 19780039
    [Abstract] [Full Text] [Related]

  • 14. Antiproliferative activity of vitamin D compounds in combination with cytostatics.
    Pelczynska M, Switalska M, Maciejewska M, Jaroszewicz I, Kutner A, Opolski A.
    Anticancer Res; 2006 Jan 10; 26(4A):2701-5. PubMed ID: 16886680
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antileukemic effect of a synthetic vitamin D3 analog, HY-11, with low potential to cause hypercalcemia.
    Yoon JS, Kim JY, Park HK, Kim ES, Ahn KS, Yoon SS, Cho CG, Kim BK, Lee YY.
    Int J Oncol; 2008 Feb 10; 32(2):387-96. PubMed ID: 18202761
    [Abstract] [Full Text] [Related]

  • 18. Side-chain-modified analogs of calcitriol cause resistance of human HL-60 promyelocytic leukemia cells to drug-induced apoptosis.
    Chrobak A, Radzikowski C, Opolski A.
    Steroids; 2005 Jan 10; 70(1):19-27. PubMed ID: 15610893
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Studies on the influence of vitamin D3 metabolites on apoptosis induction in human neoplastic cells.
    Gruber BM, Anuszewska EL.
    Acta Pol Pharm; 2003 Jan 10; 60(5):363-6. PubMed ID: 15005419
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.